David Sinclair· PhD
ER-100 to treat blindness by reversing aging
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
ER-100 to treat blindness by reversing aging
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
In January, the FDA allowed ER-100, an OSK therapy, to be tested in humans with vision loss...
@lifebiosciences will be starting human trials of ER-100 in a few months, with @MorganStanley as an investor
In anticipation of the first epigenetic age reversal drug candidate ER-100 going into humans